The lawsuits target a range of businesses that allegedly marketed ⁠retatrutide products to consumers despite the drug remaining under clinical development.

Eli Lilly is suing six companies for allegedly selling illegal retatrutide products. Retatrutide is a new glucagon-like peptide-1 (GLP-1) receptor agonist under investigation by the Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . Eli Lilly claimed six companies are selling illegal forms of retatrutide, which is not yet FDA approved. Eli ...

The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.

American drugmaker Eli Lilly has sued six companies in the US over the alleged illegal sale of its experimental weight-loss drug retatrutide.In a statement, Lilly said that the lawsuits target US ...

Eli Lilly has filed six new lawsuits against U.S. entities that it alleges are selling a version of the company’s investigational weight-loss drug on the black market.

Eli Lilly has filed six lawsuits against U.S. entities it accuses of illegally selling versions of its experimental obesity drug retatrutide. The lawsuits target compounding pharmacies, medical spas ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...